🇮🇳 AIIMS PG (DM/MCh) Entrance · subject

AIIMS PG (DM/MCh) Entrance General Medicine and Medical Super-Specialties Syllabus

The General Medicine and Medical Super-Specialties syllabus for AIIMS PG (DM/MCh) Entrance in full: 5 chapters, 23 topics and 54 sub-topics, every one listed below, plus 51 General Medicine and Medical Super-Specialties flashcards with answers.

5Chapters
23Topics
54Sub-topics
51Flashcards

General Medicine and Medical Super-Specialties syllabus: all 5 chapters

Expand any chapter to see its topics and sub-topics.

  1. Cardiology

    5 topics
    • Ischemic Heart Disease
      • Acute coronary syndromes: STEMI, NSTEMI, unstable angina
      • Coronary angiography and revascularization (PCI, CABG)
      • Secondary prevention and antiplatelet therapy
    • Heart Failure
      • HFrEF vs HFpEF pathophysiology and classification
      • Guideline-directed medical therapy (ARNI, SGLT2i, beta-blockers)
      • Device therapy: CRT and ICD indications
    • Arrhythmias and Electrophysiology
      • Atrial fibrillation: rate vs rhythm control and anticoagulation
      • Supraventricular and ventricular tachycardias
      • Bradyarrhythmias and pacemaker indications
    • Valvular and Structural Heart Disease
      • Rheumatic and degenerative valve lesions
      • Echocardiographic assessment of severity
      • TAVI and percutaneous interventions
    • Cardiomyopathies and Pericardial Disease
      • Dilated, hypertrophic and restrictive cardiomyopathy
      • Constrictive pericarditis and cardiac tamponade
  2. Nephrology

    5 topics
    • Acute Kidney Injury
      • Prerenal, intrinsic and postrenal etiologies
      • KDIGO staging and biomarkers
      • Indications for renal replacement therapy
    • Chronic Kidney Disease
      • Staging, progression and complications
      • Mineral bone disease and anemia management
    • Glomerular Diseases
      • Nephritic vs nephrotic syndromes
      • Lupus nephritis and ANCA-associated vasculitis
      • Renal biopsy interpretation
    • Dialysis and Transplantation
      • Hemodialysis and peritoneal dialysis principles
      • Immunosuppression and graft rejection
    • Fluid, Electrolyte and Acid-Base Disorders
      • Sodium and potassium disorders
      • Metabolic acidosis and alkalosis with anion gap analysis
  3. Neurology

    5 topics
    • Cerebrovascular Disease
      • Ischemic stroke: thrombolysis and thrombectomy
      • Intracerebral and subarachnoid hemorrhage
    • Seizure Disorders and Epilepsy
      • Classification and EEG correlation
      • Antiepileptic drug selection and status epilepticus
    • Movement Disorders
      • Parkinson disease and parkinsonism
      • Tremor, dystonia and chorea
    • Neuromuscular and Demyelinating Disease
      • Multiple sclerosis and NMO spectrum
      • Myasthenia gravis and Guillain-Barre syndrome
    • Headache and Neurodegeneration
      • Migraine and secondary headaches
      • Dementia syndromes and cognitive assessment
  4. Endocrinology

    4 topics
    • Diabetes Mellitus
      • Type 1 and Type 2 pathophysiology
      • Pharmacotherapy and insulin regimens
      • Acute complications: DKA and HHS
    • Thyroid Disorders
      • Hypothyroidism and hyperthyroidism
      • Thyroid nodule and cancer evaluation
    • Pituitary and Adrenal Disorders
      • Acromegaly, prolactinoma and hypopituitarism
      • Cushing syndrome and Addison disease
    • Calcium and Bone Metabolism
      • Hyper- and hypoparathyroidism
      • Osteoporosis and vitamin D disorders
  5. Gastroenterology and Hepatology

    4 topics
    • Liver Disease
      • Cirrhosis and portal hypertension
      • Viral hepatitis and acute liver failure
      • Hepatocellular carcinoma surveillance
    • Inflammatory Bowel Disease
      • Crohn disease vs ulcerative colitis
      • Biologic and immunomodulator therapy
    • Pancreaticobiliary Disease
      • Acute and chronic pancreatitis
      • Cholangitis and biliary obstruction
    • Gastrointestinal Bleeding and Motility
      • Upper and lower GI bleed management
      • GERD, achalasia and functional disorders

AIIMS PG (DM/MCh) Entrance General Medicine and Medical Super-Specialties flashcards — 51 questions with answers

  1. What ECG criterion defines STEMI in two contiguous leads (in leads other than V2-V3)?

    New ST-elevation at the J-point of at least 1 mm (0.1 mV) in two contiguous leads. For V2-V3: at least 2 mm in men 40+, at least 2.5 mm in men under 40, and at least 1.5 mm in women.

  2. In acute coronary syndrome, which artery occlusion is suggested by ST-elevation in leads II, III, and aVF?

    The right coronary artery (inferior MI). Associated RV infarction is suggested by ST-elevation in right-sided lead V4R, and these patients are preload-dependent (avoid nitrates).

  3. What is the door-to-balloon target time for primary PCI in STEMI, and the door-to-needle target for fibrinolysis?

    Door-to-balloon (first medical contact to device) within 90 minutes (or 120 min if transferred). Door-to-needle for fibrinolytics within 30 minutes.

  4. Define Type 2 myocardial infarction.

    MI secondary to an imbalance between myocardial oxygen supply and demand (e.g., from anemia, hypotension, tachyarrhythmia, coronary spasm) rather than acute atherothrombotic plaque rupture (Type 1).

  5. List the four stages (A-D) of heart failure in the ACC/AHA classification.

    A: at risk, no structural disease/symptoms. B: structural disease, no symptoms. C: structural disease with prior/current symptoms. D: refractory/advanced HF needing specialized interventions.

  6. What four drug classes form guideline-directed medical therapy (the "four pillars") for HFrEF?

    ARNI (or ACEi/ARB), beta-blocker, mineralocorticoid receptor antagonist (MRA), and SGLT2 inhibitor.

  7. What is the formula for ejection fraction and the cutoffs defining HFrEF, HFmrEF, and HFpEF?

    EF = stroke volume / end-diastolic volume. HFrEF: EF 40% or less. HFmrEF (mildly reduced): EF 41-49%. HFpEF (preserved): EF 50% or greater.

  8. Which biomarker is used to diagnose and prognosticate heart failure, and what physiology raises it?

    BNP / NT-proBNP, released from ventricular myocytes in response to wall stretch/volume overload. Levels are lowered by obesity and raised in renal failure and atrial fibrillation.

  9. State the CHA2DS2-VASc components and the points assigned.

    Congestive HF (1), Hypertension (1), Age 75+ (2), Diabetes (1), Stroke/TIA/thromboembolism (2), Vascular disease (1), Age 65-74 (1), Sex category female (1).

  10. Differentiate the mechanism of typical atrial flutter from AVNRT.

    Typical atrial flutter is a macro-reentrant circuit around the tricuspid annulus (cavotricuspid isthmus dependent), giving sawtooth flutter waves at ~300/min. AVNRT is micro-reentry within the AV node using fast and slow pathways, narrow-complex tachycardia.

  11. What is the ECG hallmark of Wolff-Parkinson-White syndrome, and which AV nodal blockers are contraindicated in pre-excited atrial fibrillation?

    Short PR interval with a delta wave (slurred QRS upstroke) due to an accessory pathway. In pre-excited AF, avoid AV nodal blockers (adenosine, verapamil, diltiazem, beta-blockers, digoxin) which can accelerate conduction down the accessory pathway and cause VF; use procainamide or cardioversion.

  12. What defines long QT and what is the characteristic associated ventricular arrhythmia?

    Prolonged corrected QT (QTc over 450 ms men, 460-470 ms women). It predisposes to torsades de pointes, a polymorphic VT, treated acutely with IV magnesium.

  13. Give the Sgarbossa criteria for diagnosing MI in the presence of LBBB.

    Concordant ST-elevation 1 mm or more (5 points), concordant ST-depression 1 mm or more in V1-V3 (3 points), and excessively discordant ST-elevation 5 mm or more (2 points). Score 3+ is specific for MI.

  14. What is the indication for transcatheter vs surgical aortic valve replacement in severe aortic stenosis, and the classic symptom triad?

    Symptomatic severe AS (mean gradient 40+ mmHg, valve area under 1 cm2, jet velocity 4+ m/s). TAVR favored in older/high-risk patients, SAVR in younger/low-risk. Classic triad: angina, syncope, exertional dyspnea/heart failure.

  15. What auscultatory findings distinguish mitral stenosis?

    Loud S1, opening snap after S2, and a low-pitched mid-diastolic rumble at the apex with presystolic accentuation (if in sinus rhythm). A shorter A2-to-opening-snap interval indicates more severe stenosis.

  16. How does the murmur of hypertrophic obstructive cardiomyopathy change with Valsalva and squatting?

    The systolic murmur INCREASES with maneuvers that decrease preload/afterload (Valsalva strain, standing) and DECREASES with squatting/handgrip (increased afterload/venous return). This opposes the behavior of aortic stenosis.

  17. What is the most common cause of mitral regurgitation requiring surgery in developed countries, and the indication for intervention in chronic primary MR?

    Degenerative/myxomatous disease (mitral valve prolapse). Intervene when symptomatic, or asymptomatic with LVEF 60% or less, LV end-systolic diameter 40 mm or more, new AF, or pulmonary hypertension.

  18. Differentiate the four major cardiomyopathy types by their primary functional abnormality.

    Dilated: systolic dysfunction with chamber dilation. Hypertrophic: diastolic dysfunction, asymmetric septal hypertrophy. Restrictive: impaired ventricular filling with preserved/near-normal EF. Arrhythmogenic RV: fibrofatty RV replacement causing arrhythmias.

  19. What distinguishes constrictive pericarditis from restrictive cardiomyopathy hemodynamically?

    Constriction shows ventricular interdependence (discordant LV/RV systolic pressures with respiration), pericardial knock, septal bounce, and equalization of diastolic pressures with normal BNP and pericardial calcification. Restriction shows concordant pressures, high BNP, and biatrial enlargement.

  20. What is Beck's triad of cardiac tamponade, and the key echo finding?

    Hypotension, muffled heart sounds, and elevated JVP (distended neck veins). Echo shows diastolic right-ventricular and right-atrial collapse; pulsus paradoxus (over 10 mmHg inspiratory drop in SBP) is the clinical hallmark.

Show the other 31 General Medicine and Medical Super-Specialties flashcards
  1. Give the KDIGO definition (criteria) for acute kidney injury.

    Any of: rise in serum creatinine of 0.3 mg/dL or more within 48 hours; rise to 1.5 times baseline within 7 days; or urine output under 0.5 mL/kg/hr for 6 hours.

  2. How do FENa and urine osmolality help distinguish prerenal azotemia from acute tubular necrosis?

    Prerenal: FENa under 1%, urine osmolality over 500 mOsm/kg, BUN/Cr ratio over 20:1, bland sediment. ATN: FENa over 2%, urine osmolality near 300 (isosthenuria), muddy brown granular casts. FENa = (UNa x PCr)/(PNa x UCr) x 100.

  3. What are the absolute (emergent) indications for dialysis in AKI? (mnemonic AEIOU)

    Acidosis (refractory metabolic), Electrolytes (refractory hyperkalemia), Intoxications (dialyzable toxins), Overload (refractory volume overload/pulmonary edema), Uremia (pericarditis, encephalopathy, bleeding).

  4. State the CKD GFR (G) staging categories per KDIGO.

    G1: 90+ (with kidney damage), G2: 60-89, G3a: 45-59, G3b: 30-44, G4: 15-29, G5: under 15 (kidney failure). Albuminuria categories A1 (<30), A2 (30-300), A3 (>300 mg/g).

  5. Which equation is used to estimate GFR and what variables does the 2021 CKD-EPI creatinine equation use?

    CKD-EPI 2021 uses serum creatinine, age, and sex (the race coefficient was removed). Cystatin C-based equations improve accuracy. Cockcroft-Gault estimates creatinine clearance using age, weight, sex, and creatinine.

  6. Name the classic nephrotic and nephritic glomerular diseases and their distinguishing feature.

    Nephrotic (proteinuria >3.5 g/day, hypoalbuminemia, edema): minimal change, FSGS, membranous, diabetic, amyloid. Nephritic (hematuria, RBC casts, HTN, mild proteinuria): post-strep GN, IgA nephropathy, anti-GBM, ANCA vasculitis, lupus, MPGN.

  7. What is the most common cause of nephrotic syndrome in adults vs children, and the key feature of each?

    Adults: focal segmental glomerulosclerosis (and membranous, often anti-PLA2R antibody positive). Children: minimal change disease (foot process effacement on EM, steroid-responsive).

  8. What characterizes IgA nephropathy clinically and histologically?

    Most common primary glomerulonephritis worldwide; presents with synpharyngitic gross hematuria (1-2 days after URI). Mesangial IgA deposition on immunofluorescence. Differs from post-strep GN, which occurs 1-3 weeks after infection with low complement.

  9. Compare the timing and complement levels of post-streptococcal GN vs IgA nephropathy.

    PSGN: 1-3 weeks after pharyngitis/skin infection, LOW C3, subepithelial humps on EM. IgA: 1-2 days after URI (synpharyngitic), NORMAL complement, mesangial deposits.

  10. Differentiate hemodialysis from peritoneal dialysis in mechanism of solute clearance.

    Hemodialysis clears solutes by diffusion across a semipermeable membrane (with convection via ultrafiltration) using extracorporeal blood. Peritoneal dialysis uses the peritoneum as the membrane, with diffusion and osmotic ultrafiltration driven by dextrose in dialysate.

  11. Which kidney transplant rejection types correspond to T-cell vs antibody-mediated mechanisms, and the timing of hyperacute rejection?

    T-cell-mediated (cellular) rejection: tubulitis/interstitial infiltrate, days to weeks. Antibody-mediated: peritubular capillaritis, C4d positive, donor-specific antibodies. Hyperacute occurs within minutes-hours due to preformed antibodies (preventable by crossmatch).

  12. Give the formulas for the anion gap and the expected respiratory (Winter's) compensation in metabolic acidosis.

    Anion gap = Na - (Cl + HCO3), normal 8-12. Winter's formula: expected PCO2 = 1.5 x [HCO3] + 8 (plus or minus 2). If measured PCO2 is higher, there is a concurrent respiratory acidosis; if lower, concurrent respiratory alkalosis.

  13. List the causes of a high anion gap metabolic acidosis (mnemonic GOLD MARK).

    Glycols (ethylene, propylene), Oxoproline, L-lactate, D-lactate, Methanol, Aspirin, Renal failure, Ketoacidosis. (Classic MUDPILES is an alternative.)

  14. How is the corrected sodium calculated in hyperglycemia, and the correction for sodium in hyponatremia?

    Corrected Na = measured Na + 1.6 (or 2.4) mEq/L for every 100 mg/dL glucose above 100. Acute hyponatremia correction should not exceed ~8 mEq/L per 24 hours to avoid osmotic demyelination syndrome.

  15. What ECG changes occur with progressive hyperkalemia, and the first drug to give?

    Peaked T waves, then PR prolongation/flattened P, widened QRS, sine wave, and asystole/VF. First give IV calcium gluconate to stabilize the myocardium (does not lower K); then shift K with insulin/glucose, beta-agonists, bicarbonate.

  16. Differentiate ischemic stroke subtypes by the TOAST classification.

    Large-artery atherosclerosis, cardioembolism, small-vessel occlusion (lacunar), stroke of other determined etiology, and stroke of undetermined etiology (cryptogenic).

  17. What are the time windows for IV thrombolysis (alteplase/tenecteplase) and mechanical thrombectomy in acute ischemic stroke?

    IV thrombolysis up to 4.5 hours from onset. Mechanical thrombectomy for large-vessel occlusion up to 24 hours in selected patients with favorable perfusion imaging (DAWN/DEFUSE-3 criteria).

  18. What blood pressure threshold permits IV thrombolysis, and the target in spontaneous intracerebral hemorrhage?

    BP must be below 185/110 mmHg before and 180/105 after thrombolysis. In acute ICH, lowering SBP to ~140 mmHg (INTERACT/ATACH targets) is reasonable. In untreated ischemic stroke, permissive hypertension up to 220/120 is allowed.

  19. Define status epilepticus and the first- and second-line drug treatments.

    Continuous seizure 5+ minutes, or recurrent seizures without recovery of consciousness. First-line: IV benzodiazepine (lorazepam/diazepam) or IM midazolam. Second-line: IV levetiracetam, fosphenytoin/phenytoin, or valproate.

  20. Differentiate focal vs generalized seizures and give the drug of choice for absence seizures.

    Focal seizures begin in one hemisphere (with/without awareness); generalized involve both hemispheres at onset (e.g., absence, tonic-clonic, myoclonic). Drug of choice for absence seizures is ethosuximide (or valproate).

  21. What is the pathophysiology of Parkinson disease and its cardinal motor features?

    Loss of dopaminergic neurons in the substantia nigra pars compacta with Lewy bodies (alpha-synuclein). Cardinal features: bradykinesia, resting tremor (4-6 Hz, pill-rolling), rigidity (cogwheel), and postural instability.

  22. Differentiate essential tremor from Parkinsonian tremor and Huntington disease genetics.

    Essential tremor: action/postural tremor, improves with alcohol, treated with propranolol/primidone. Parkinsonian: resting tremor. Huntington: autosomal dominant CAG trinucleotide repeat expansion in HTT gene with chorea, caudate atrophy, anticipation.

  23. Contrast Guillain-Barre syndrome with myasthenia gravis in pathophysiology and key tests.

    GBS: acute ascending areflexic paralysis, post-infectious (Campylobacter), albuminocytologic dissociation in CSF, autoimmune demyelination. Myasthenia gravis: anti-AChR (or MuSK) antibodies, fatigable weakness, decremental response on repetitive nerve stimulation, thymoma association.

  24. What distinguishes the antibodies and weakness pattern of Lambert-Eaton from myasthenia gravis?

    Lambert-Eaton: anti-voltage-gated calcium channel antibodies, paraneoplastic (small cell lung cancer), weakness IMPROVES with repeated use (incremental response), proximal weakness with hyporeflexia. Myasthenia: anti-AChR, weakness WORSENS with use.

  25. List the McDonald-relevant features and first-line acute treatment of multiple sclerosis.

    MS requires dissemination in space and time (CNS demyelination); MRI shows periventricular/juxtacortical/infratentorial/spinal lesions, CSF oligoclonal bands. Acute relapses treated with high-dose IV methylprednisolone; relapsing disease with disease-modifying therapies.

  26. Differentiate the major primary headaches: migraine, tension-type, and cluster.

    Migraine: unilateral, pulsating, 4-72 hr, photophobia/phonophobia/nausea, +/- aura. Tension: bilateral, pressing, non-pulsatile, no nausea. Cluster: severe unilateral orbital pain, 15-180 min, with ipsilateral autonomic features (lacrimation, ptosis), male predominance.

  27. What protein pathologies underlie Alzheimer disease, and the characteristic CSF/imaging findings?

    Extracellular beta-amyloid plaques and intracellular neurofibrillary tangles of hyperphosphorylated tau. CSF shows low Abeta42 and high tau/p-tau; MRI shows hippocampal/medial temporal atrophy. Anti-amyloid monoclonal antibodies (lecanemab) are disease-modifying options.

  28. State the diagnostic thresholds for diabetes mellitus.

    Fasting plasma glucose 126+ mg/dL, 2-hour OGTT 200+ mg/dL, HbA1c 6.5%+, or random glucose 200+ with symptoms. Prediabetes: FPG 100-125, A1c 5.7-6.4%, OGTT 140-199.

  29. Differentiate DKA from hyperosmolar hyperglycemic state.

    DKA: glucose usually 250-600, marked ketonemia/ketonuria, high anion gap metabolic acidosis (pH <7.3, HCO3 <18), in type 1. HHS: glucose often >600, serum osmolality >320, minimal ketosis, pH >7.3, profound dehydration, in type 2; higher mortality.

  30. How are primary, secondary, and tertiary hyperthyroidism distinguished by TSH/T4, and what is the most common cause of hyperthyroidism?

    Primary (Graves): low TSH, high free T4 (TSH-receptor antibodies, diffuse uptake). Secondary (TSH-secreting adenoma): high TSH, high T4. Subclinical: low TSH, normal T4. Graves disease is the most common cause of hyperthyroidism.

  31. Differentiate Cushing syndrome screening tests and the dexamethasone suppression interpretation.

    Screen with late-night salivary cortisol, 24-hr urinary free cortisol, or 1 mg overnight dexamethasone suppression test (cortisol fails to suppress). ACTH-dependent (pituitary/ectopic) vs ACTH-independent (adrenal). High-dose dexamethasone suppresses pituitary (Cushing disease) but not ectopic ACTH.

AIIMS PG (DM/MCh) Entrance General Medicine and Medical Super-Specialties FAQ

What is in the AIIMS PG (DM/MCh) Entrance General Medicine and Medical Super-Specialties syllabus?

AIIMS PG (DM/MCh) Entrance General Medicine and Medical Super-Specialties is split into 5 chapters: Cardiology, Nephrology, Neurology, Endocrinology and Gastroenterology and Hepatology. Together they contain 23 topics and 54 sub-topics.

How many chapters are in AIIMS PG (DM/MCh) Entrance General Medicine and Medical Super-Specialties?

5 chapters, containing 23 topics and 54 sub-topics. The largest chapter is Cardiology, with 5 topics.

Are there flashcards for AIIMS PG (DM/MCh) Entrance General Medicine and Medical Super-Specialties?

Yes — a 51-card General Medicine and Medical Super-Specialties deck, printed in full in the flashcards section of this page and available in the Examius app with spaced repetition. The free plan covers one exam of your choice, including its flashcards; Examius Pro, a one-time purchase, unlocks every other exam and deck.